COMPARE · Data as of August 21, 2026

DOCS vs HQY

Verdict: Side-by-side breakdown using the Bull Rankings model. DOCS scored 84.1, HQY scored 66.5 — DOCS leads.
Compare another set
DOCS
Doximity, Inc.
Health Information Services · Quality-Growth
84.1
$25.33 · $4.5B
fundamentals as of
Score gap
17.6
DOCS leads
HQY
HealthEquity, Inc.
Health Information Services · Quality-Growth
66.5
$105.41 · $8.8B
fundamentals as of
  • CheapestDOCS30.2x
  • Fastest growthDOCS+11.2%
  • Strongest balance sheetDOCS0.01
  • Highest qualityDOCS89 / 100
  • Largest discount to fair valueDOCS-8%
THE BULL RANKINGS SCORECARD84.1/ 100 · BULL SCOREPEER MEDIANQUALITY88.6GROWTH85.0VALUE78.9
THE BULL RANKINGS SCORECARD66.5/ 100 · BULL SCOREPEER MEDIANQUALITY70.6GROWTH62.3VALUE66.9
DOCSHQYQuality88.670.6Growth85.062.3Value78.966.9
cheap & fastrevenue growth →← cheaper (lower multiple)-2%21%25x44xDOCSHQY

Growth against the P/E multiple. Up and to the right is cheaper and faster — the quality-growth idea in one picture. Points beyond the axis are pinned to the edge and marked off-scale rather than allowed to compress everything else.

FCFDOCS$306mHQY$488m
RevDOCS+11.2%HQY+7.6%
D/EDOCS0.01HQY0.48
P/EDOCS30.2xHQY39.5x
PEGDOCS0.59HQY1.35
DOCS
stronger →← stronger
HQY
89
Qualityreturns · margins · balance sheet
71
85
Growthrevenue & earnings expansion
62
79
Valuevaluation vs sector peers
67
DOCS is stronger on 3 of 3 pillars.
DOCS
HQY
$306mC
FCF
$488mC
+11.2%B
Rev
+7.6%B
0.01A-
D/E
0.48B
30.2xB
P/E
39.5xC+
0.59A-
PEG
1.35B
Winner per row is the stronger grade; where grades tie, the better figure breaks it. A true tie or a missing value shows no highlight.
DOCS
HQY
8% below
Price vs fair valuelower is cheaper
6% below
~7%/yr
Growth the price implies10-yr FCF · lower = less priced in
~8%/yr
-5%
1-yr DCF upside
-9%
+9%
5-yr DCF upside
+7%
+33%
10-yr DCF upside
+34%
The DCF is a cross-check on intrinsic value, separate from the quality-growth score above.
DOCS
Why this score
  • Durable high returns
HQY
Why this score
  • Buying back stock
DOCSDoximity, Inc.
Health Information Services · $25.33 · beta 1.21
Why now
Health Information Services · market cap $4.5b. Down 67% from 52-week high of $76.51 — deep drawdown territory. Revenue growing +11%, comfortably above the S&P median. PEG 0.59 — paying under fair value for the growth rate. 18 sell-side analysts rate this a Hold with a mean 1-yr target of $29.39 (implying +16% upside).
Moat
Net margin 25% sits well above the S&P median (~11%) — suggests structural pricing advantage or cost discipline competitors can't quickly close. ROE 18% sits above Buffett's preferred 15% threshold — the equity base is compounding at a rate the market struggles to discount accurately. FCF converts 183% of net income — earnings translate cleanly into cash, a sign that working capital and capex are well-disciplined.
Risk
Down 67% from the 52-week high — the market is pricing in something the screen can't see; verify the bear case before sizing up. Trailing P/E 30x sits well above the S&P median (~20x) — multiple compression is a real risk if revenue growth decelerates.
HQYHealthEquity, Inc.
Health Information Services · $105.41 · beta 0.23
Why now
Health Information Services · market cap $8.8b. Trading near 52-week high of $107.62 — momentum setup, limited technical margin of safety. 15 sell-side analysts rate this a Strong Buy with a mean 1-yr target of $118.53 (implying +12% upside).
Moat
Net margin 17% beats the market median by a meaningful margin — the company is keeping more of every revenue dollar than the average S&P constituent. ROE 11% meets the long-run market sustainable threshold — solid but not differentiated; the durability comes from elsewhere. Free cash flow runs well ahead of reported net income — non-cash charges (depreciation, intangible amortization) are holding down GAAP earnings while cash generation stays strong.
Risk
Trading within 2% of the 52-week high — limited technical margin of safety; a momentum reversal would test conviction. Trailing P/E 39x sits well above the S&P median (~20x) — multiple compression is a real risk if revenue growth decelerates.
Generating verdict… typically 5–10 seconds
Not investment advice. The Bull Rankings publishes a quantitative ranking model and accompanying analysis for general informational purposes only. Nothing on this page is a recommendation to buy, sell, or hold any security; nothing is personalized to your circumstances, risk tolerance, or tax situation. Investing carries the risk of loss — invest at your own risk and consider consulting a licensed financial professional before acting on anything you read here. See terms and methodology for full disclosures.

Where DOCS and HQY diverge

On the headline score the gap is 17.6 points in favor of DOCS. The widest single difference is Growth, where DOCS leads by 22.7 points.

Pillars run 0–100 against sector peers, so a score is a statement about a company relative to its own industry rather than to the other name here. A wide Value gap usually means the market already prices the difference in quality or growth — which is the trade-off this comparison comes down to.